Lightengale develops medical devices for improved ICU infusion lines.
Lightengale provides devices that aim to mitigate potentially dangerous errors by using light-emitting cables that help nurses illuminate individual IV lines from pump to patient, thereby reducing line mix-ups and decreasing medication delivery errors, enabling nurses to get the valuable time to focus on their patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 13, 2021 | Grant | $255.95K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |